Enamine is the world’s largest supplier of the drug-like molecules for drug discovery research. In 2011, Enamine announced opening of a contract research laboratory (CRO) for bioscreening and ADMET testing services at its main research site in Kiev, Ukraine. Since June 2013, Enamine’s biological testing services will be offered under a trademark of Bienta. Bienta is providing biomolecular screening and ADMET services for drug discovery and operates in the tight integration with Enamine’s powerful synthetic chemistry and screening compound collection platform.
“Bien” has the meanings of “good”, “proper” or “benefit” in Spanish and French. Indeed, entrusting your early stage drug discovery projects to Bienta, you are putting them in good hands. Take a look at the list of our services to learn how we can provide you with a reliable and time and cost-effective hit finding, hit-to-lead, as well as lead optimization support.